138 related articles for article (PubMed ID: 38304689)
1. Navigating Novel Uncertainties of COVID-19: The Rise of the JN.1 Variant.
Altamimi I; Alabdulkarim IM; Alhumimidi AS; Albabtain MA; Temsah MH
Cureus; 2024 Jan; 16(1):e51497. PubMed ID: 38304689
[TBL] [Abstract][Full Text] [Related]
2. Exploring New COVID-19 Incertitude: JN.1 Variant- JN.1: The Queer Bird Among Omicron Sublineages.
Ray SK; Mukherjee S
Infect Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38939989
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
[TBL] [Abstract][Full Text] [Related]
4. Appearance and Prevalence of JN.1 SARS-CoV-2 Variant in India and Its Clinical Profile in the State of Maharashtra.
Karyakarte RP; Das R; Rajmane MV; Dudhate S; Agarasen J; Pillai P; Chandankhede PM; Labhshetwar RS; Gadiyal Y; Kulkarni PP; Nizarudeen S; Yanamandra S; Taji N; Joshi S; Potdar V
Cureus; 2024 Mar; 16(3):e56718. PubMed ID: 38646375
[TBL] [Abstract][Full Text] [Related]
5. JN.1 and the ongoing battle: unpacking the characteristics of a new dominant COVID-19 variant.
Eshraghi R; Bahrami A; Karimi Houyeh M; Nasr Azadani M
Pathog Glob Health; 2024 Jun; ():1-6. PubMed ID: 38884317
[TBL] [Abstract][Full Text] [Related]
6. Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.
Mediavilla JR; Lozy T; Lee A; Kim J; Kan VW; Titova E; Amin A; Zody MC; Corvelo A; Oschwald DM; Baldwin A; Fennessey S; Zuckerman JM; Kirn T; Chen L; Zhao Y; Chow KF; Maniatis T; Perlin DS; Kreiswirth BN
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632041
[TBL] [Abstract][Full Text] [Related]
7. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
[TBL] [Abstract][Full Text] [Related]
8. Evolving immune evasion and transmissibility of SARS-CoV-2: The emergence of JN.1 variant and its global impact.
Ou G; Yang Y; Zhang S; Niu S; Cai Q; Liu Y; Lu H
Drug Discov Ther; 2024 Mar; 18(1):67-70. PubMed ID: 38382991
[TBL] [Abstract][Full Text] [Related]
9. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
10. Omicron new variant BA.2.86 (Pirola): Epidemiological, biological, and clinical characteristics - a global data-based analysis.
Meo SA; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9470-9476. PubMed ID: 37843359
[TBL] [Abstract][Full Text] [Related]
11. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
Akkız H
Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
[TBL] [Abstract][Full Text] [Related]
12. The emerging challenge of FLiRT variants: KP.1.1 and KP.2 in the global pandemic landscape.
Kumar P; Jayan J; Sharma RK; Gaidhane AM; Syed Zahiruddin Q; Rustagi S; Satapathy P
QJM; 2024 Jun; ():. PubMed ID: 38867702
[TBL] [Abstract][Full Text] [Related]
13. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
Elife; 2022 Aug; 11():. PubMed ID: 36004719
[TBL] [Abstract][Full Text] [Related]
14. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
15. Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2.
Parums DV
Med Sci Monit; 2023 Sep; 29():e942244. PubMed ID: 37654205
[TBL] [Abstract][Full Text] [Related]
16. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
17. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
[TBL] [Abstract][Full Text] [Related]
18. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
medRxiv; 2022 Jan; ():. PubMed ID: 35118480
[TBL] [Abstract][Full Text] [Related]
19. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
[TBL] [Abstract][Full Text] [Related]
20. Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.
Chavda VP; Yao Q; Vora LK; Apostolopoulos V; Patel CA; Bezbaruah R; Patel AB; Chen ZS
Front Immunol; 2022; 13():961198. PubMed ID: 36263030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
